Class II · Moderate risk
fentaNYL 2 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium…
Lack of assurance of sterility:
FDA Drug Recalls
14,806 recalls, newest first
Class II · Moderate risk
fentaNYL 2 mcg/mL and bupivacaine 0.0625% PF in 0.9% sodium chloride
Lack of assurance of sterility:
Class II · Moderate risk
fentaNYL 1.5 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium…
Lack of assurance of sterility:
Class II · Moderate risk
fentaNYL in 0.9% sodium chloride
Lack of assurance of sterility:
Class II · Moderate risk
fentaNYL in 0.9% sodium chloride
Lack of assurance of sterility:
Class II · Moderate risk
fentaNYL in 0.9% sodium chloride
Lack of assurance of sterility:
Class II · Moderate risk
fentaNYL in 0.9% sodium chloride
Lack of assurance of sterility:
Class II · Moderate risk
fentaNYL in 0.9% sodium chloride
Lack of assurance of sterility:
Class II · Moderate risk
fentaNYL in 0.9% sodium chloride
Lack of assurance of sterility:
Class II · Moderate risk
rocuronium
Lack of assurance of sterility:
Class II · Moderate risk
PHENYLephrine in 0.9% sodium chloride
Lack of assurance of sterility:
Class II · Moderate risk
PHENYLephrine in 0.9 sodium chloride
Lack of assurance of sterility:
Class II · Moderate risk
PHENYLephrine in 0.9 sodium chloride
Lack of assurance of sterility:
Class II · Moderate risk
lidocaine 2%
Lack of assurance of sterility:
Class II · Moderate risk
ePHEDrine in 0.9% sodium chloride
Lack of assurance of sterility:
Class II · Moderate risk
ketamine in 0.9% sodium chloride
Lack of assurance of sterility:
Class II · Moderate risk
fentaNYL in 0.9% sodium chloride
Lack of assurance of sterility:
Class I · High risk
Betaxolol Tablets
Presence of Foreign Tablets/Capsules: There is a potential presence of oxycodone HCl tablets, USP 5 mg in bottles.
Class III · Low risk
MYDRIATIC-4: Tropicamide - Proparacaine - Phenylephrine -…
Subpotent: Out of Specification result observed for Ketorolac assay levels, below the 90.0-110.0% of label claim.
Class III · Low risk
Eligard (leuprolide acetate)
Superpotent Drug - Higher than expected levels of leuprolide acetate in the constituted product.
Class III · Low risk
Cequa (cyclosporine ophthalmic solution)
Subpotent: Out of Specification result observed for low assay
Class III · Low risk
Kroger Mint Burst ANTISEPTIC MOUTH RINSE ANTIGINGIVITIS/ANTIPLAQUE
Incorrect/Undeclared Excipients.
Class II · Moderate risk
Pantoprazole Sodium for Injection 40mg per vial
Lack of Assurance of Sterility: Powder discoloration due to small crack in some vials.
Class III · Low risk
HydrALAZINE Hydrochloride Tablets
Failed Impurities/Degradation Specifications: Out of Specification results in the repackaged product for impurities at the 12-month time point.
Class II · Moderate risk
Sucralfate Oral Suspension 1g per 10mL
Superpotent/Subpotent single ingredient Drug: Out of Specification Assay results